期刊
CANCER INVESTIGATION
卷 31, 期 3, 页码 197-205出版社
TAYLOR & FRANCIS INC
DOI: 10.3109/07357907.2013.775294
关键词
Adoptive immunotherapy; Non-small cell lung cancer; Clinical study; Influence factor
类别
资金
- National Basic Research Program of China (973 Program) [2012CB9333004]
- National High Technology Research and Development Program of China (863 Program) [SS2012AA020403]
Non-small cell lung cancer (NSCLC) is found worldwide with high incidence and poor prognoses. Nowadays, insights in the interaction between tumors and immune system have led to the development of immunotherapy as a fundamentally new concept for the treatment of NSCLC. Adoptive cell transfer represents an important advancement in cancer immunotherapy such as cytokine-induced killer and gamma delta T-cells. Recent clinical research studies provide evidence for the positive effects of adoptive immunotherapy, which is probably associated with levels of cytokines, cell doses, and immune microenvironment. This review summarizes the current condition of adoptive immunotherapy in NSCLC and the long-standing confusion in this field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据